Thyroid Emergencies

Medical Clinics of North America

Volumn 96, Issue 2, 2012, Pages 385-403

  Klubo Gwiezdzinska, Joanna ^a,b   Wartofsky, Leonard ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Diagnosis; Management; Myxedema coma; Thyrotoxic storm

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIMAZOLE; CARNITINE; COLECALCIFEROL; COLESTYRAMINE; CONIVAPTAN; DOPAMINE; ESMOLOL; FUROSEMIDE; HYDROCORTISONE; HYPERTENSIVE FACTOR; INFUSION FLUID; IODIDE; IODINE; IOPANOIC ACID; IOPODATE SODIUM; LIOTHYRONINE; LITHIUM CARBONATE; LUGOL; PARACETAMOL; PROPRANOLOL; PROPYLTHIOURACIL; SALICYLIC ACID; SODIUM CHLORIDE; SODIUM IODIDE; STEROID; THIAMAZOLE; THYROID HORMONE; THYROXINE;

AIRWAY; ARTIFICIAL VENTILATION; CLINICAL FEATURE; CONTINUOUS INFUSION; DIAGNOSTIC ACCURACY; ELECTROLYTE DISTURBANCE; FEVER; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HEMATOLOGIC DISEASE; HORMONAL THERAPY; HUMAN; HYPONATREMIA; HYPOTENSION; HYPOTHERMIA; HYPOTHYROIDISM; KIDNEY DISEASE; LOADING DRUG DOSE; MEDICAL LITERATURE; MYXEDEMA; MYXEDEMA COMA; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY SYSTEM; REVIEW; RISK REDUCTION; THYROID CRISIS; THYROID DISEASE; THYROIDECTOMY;

ADRENERGIC BETA-ANTAGONISTS; ANTITHYROID AGENTS; COMA; EMERGENCIES; HUMANS; IODIDES; MYXEDEMA; THYROID CRISIS; THYROID FUNCTION TESTS; THYROID GLAND;

EID: 84858761164     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.01.015     Document Type: Review

References (118)

1. Rodriguez I., Fluiters E., Perez-Mendez L.F., et al. Factors associated with mortality of patients with myxedema coma: prospective study in 11 cases treated in a single institution. J Endocrinol 2004, 80:347-350.
2. Blignault E.J. Advanced pregnancy in severely myxedematous patient. A case report and review of the literature. S Afr Med J 1980, 57:1050-1051.
3. Patel S., Robinson S., Bidgood R.J., et al. A pre-eclamptic-like syndrome associated with hypothyroidism during pregnancy. Q J Med 1991, 79:435-441.
4. Mathew V., Misgar R.A., Ghosh S., et al. Myxedema coma: a new look into an old crisis. J Thyroid Res 2011, 2011:493462.
5. Dutta P., Bhansali A., Masoodi S.R., et al. Predictors of outcome in myxedema coma: a study from a tertiary care centre. Crit Care 2008, 12:1-8.
6. Klubo-Gwiezdzinska J., Wartofsky L. Myxedema coma. Oxford textbook of endocrinology and Diabetes 2011, 537-543. Oxford Univ. Press, Oxford. 2nd edition.
7. Kwaku M.P., Burman K.D. Myxedema coma. J Intensive Care Med 2007, 22:224-231.
8. Church C.O., Callen E.C. Myxedema coma associated with combination aripiprazole and sertraline therapy. Ann Pharmacother 2009, 43:2113-2116.
9. Chu M., Seltzer T.F. Myxedema coma induced by ingestion of raw bok choy. N Engl J Med 2010, 20(362):1945-1946.
10. Reinhardt W., Mann K. Incidence, clinical picture and treatment of hypothyroid coma. Results of a survey. Med Klin 1997, 92:521-524.
11. Jansen H.J., Doebe S.R., Louwerse E.S., et al. Status epilepticus caused by a myxedema coma. Neth J Med 2006, 64:202-205.
12. Zwillich C.W., Pierson D.J., Hofeldt F.D., et al. Ventilatory control in myxedema and hypothyroidism. N Engl J Med 1975, 292:662-665.
13. Ladenson P.W., Goldenheim P.D., Ridgway E.C. Prediction of reversal of blunted respiratory responsiveness in patients with hypothyroidism. Am J Med 1988, 84:877-883.
14. Birring S.S., Patel R.B., Parker D., et al. Airway function and markers of airway inflammation in patients with treated hypothyroidism. Thorax 2005, 60:249-253.
15. Schenck J.B., Rizvi A.A., Lin T. Severe primary hypothyroidism manifesting with torsades de pointes. Am J Med Sci 2006, 331:154-156.
16. Skowsky R.W., Kikuchi T.A. The role of vasopressin in the impaired water excretion of myxedema. Am J Med 1978, 64:613-621.
17. DeRubertis F.R., Michelis M.F., Bloom M.E., et al. Impaired water excretion in myxedema. Am J Med 1971, 51:41-53.
18. Ardalan M.R., Ghabili K., Mirnour R., et al. Hypothyroidism-induced rhabdomyolysis and renal failure. Ren Fail 2011, 33:553-554.
19. Nikolaidou C., Gouridou E., Ilonidis G., et al. Acute renal dysfunction in a patient presenting with rhabdomyolysis due to hypothyroidism attributed to Hashimoto's disease. Hippokratia 2010, 4:281-283.
20. Kar P.M., Hirani A., Allen M.J. Acute renal failure in a hypothyroid patient with rhabdomyolysis. Clin Nephrol 2003, 60:428-429.
21. Birewar S., Oppenheimer M., Zawada E.T. Hypothyroid acute renal failure. S D J Med 2004, 57:109-110.
22. Ji J.S., Chae H.S., Cho Y.S., et al. Myxedema ascites: case report and literature review. J Korean Med Sci 2006, 21:761-764.
23. Fukunaga K. Refractory gastrointestinal bleeding treated with thyroid hormone replacement. J Clin Gastroenterol 2001, 33:145-147.
24. Bergeron E., Mitchell A., Heyen F., et al. Acute colonic surgery and unrecognized hypothyroidism: a warning. Report of six cases. Dis Colon Rectum 1997, 40:859-861.
25. Manfredi E., van Zaane B., Gerdes V.E., et al. Hypothyroidism and acquired von Willebrand's syndrome: a systematic review. Haemophilia 2008, 14:423-433.
26. Michiels J.J., Schroyens W., Berneman Z., et al. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin Appl Thromb Hemost 2001, 7:113-115.
27. Hooper M.J. Diminished TSH secretion during acute non-thyroidal illness in untreated primary hypothyroidism. Lancet 1976, 1:48-49.
28. Wartofsky L., Burman K.D. Alterations in thyroid function in patients with systemic illness: the 'euthyroid sick syndrome'. Endocr Rev 1982, 3:164-217.
29. Nicoloff J.T. Thyroid storm and myxedema coma. Med Clin North Am 1985, 69:1005-1017.
30. Holvey D.N., Goodner C.J., Nicoloff J.T., et al. Treatment of myxedema coma with intravenous thyroxine. Arch Intern Med 1964, 113:139-146.
31. Ridgway E.C., McCammon J.A., Benotti J., et al. Acute metabolic responses in myxedema to large doses of intravenous l-thyroxine. Ann Intern Med 1972, 77:549-555.
32. Yamamoto T., Fukuyama J., Fujiyoshi A. Factors associated with mortality of myxedema coma: report of eight cases and literature survey. Thyroid 1999, 9:1167-1174.
33. Chernow B., Burman K.D., Johnson D.L., et al. T3 may be a better agent than T4 in the critically ill hypothyroid patient: evaluation of transport across the blood-brain barrier in a primate model. Crit Care Med 1983, 11:99-104.
34. McKerrow S.D., Osborn L.A., Levy H., et al. Myxedema-associated cardiogenic shock treated with triiodothyronine. Ann Intern Med 1992, 117:1014-1015.
35. Hylander B., Rosenqvist U. Treatment of myxedema coma: factors associated with fatal outcome. Acta Endocrinol (Copenh) 1985, 108:65-71.
36. Wartofsky L. Myxedema coma. Endocrinol Metab Clin North Am 2006, 35:687-698.
37. McCulloch W., Price P., Hinds C.J., et al. Effects of low dose oral triiodothyronine in myxedema coma. Intensive Care Med 1985, 11:259-262.
38. Vachharajani T.J., Zaman F., Abreo K.D. Hyponatremia in critically ill patients. J Intensive Care Med 2003, 18:3-8.
39. Pereira V.G., Haron E.S., Lima-Neto N., et al. Management of myxedema coma: report on three successfully treated cases with nasogastric or intravenous administration of triiodothyronine. J Endocrinol Invest 1982, 5:331-334.
40. Verbalis J.G., Goldsmith S.R., Greenberg A., et al. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 2007, 120:1-21.
41. Vaprisol (conivaptan HCl injection) 2006, [package insert], Astellas Tokai Co, Deerfield (IL).
42. Hline S.S., Pham P.T., Pham P.T., et al. Conivaptan: a step forward in the treatment of hyponatremia. Ther Clin Risk Manag 2008, 4:315-326.
43. Li-Ng M., Verbalis J.G. Conivaptan: evidence supporting its therapeutic use in hyponatremia. Core Evid 2010, 4:83-92.
44. Devdhar M., Ousman Y.H., Burman K.D. Hypothyroidism. Endocrinol Metab Clin North Am 2007, 36:595-615.
45. Jordan R.M. Myxedema coma. Pathophysiology, therapy, and factors affecting prognosis. Med Clin North Am 1995, 79:185-194.
46. Swinburne J.L., Kreisman S.H. A rare case of subacute thyroiditis causing thyroid storm. Thyroid 2007, 17:73-76.
47. Yoon S.J., Choi S.R., Kim D.M., et al. A case of thyroid storm due to thyrotoxicosis factitia. Yonsei Med J 2003, 44:351-354.
48. Klubo-Gwiezdzinska J., Wartofsky L. Thyrotoxic storm. Oxford textbook of endocrinology and diabetes 2011, 454-461. Oxford Univ. Press, Oxford. 2nd edition.
49. Tewari K., Balderston K.D., Carpenter S.E., et al. Papillary thyroid carcinoma manifesting as thyroid storm of pregnancy: case report. Am J Obstet Gynecol 1998, 179:818-819.
50. McDermott M.T., Kidd G.S., Dodson L.E., et al. Radioiodine-induced thyroid storm. Am J Med 1983, 75:353-359.
51. Naito Y., Sone T., Kataoka K., et al. Thyroid storm due to functioning metastatic thyroid carcinoma in a burn patient. Anesthesiology 1997, 87:433-435.
52. Al-Anazi K.A., Inam S., Jeha M.T., et al. Thyrotoxic crisis induced by cytotoxic chemotherapy. Support Care Cancer 2005, 13:196-198.
53. Sebe A., Satar S., Sari A. Thyroid storm induced by aspirin intoxication and the effect of hemodialysis: a case report. Adv Ther 2004, 21:173-177.
54. Hirvonen E.A., Niskanen L.K., Niskanen M.M. Thyroid storm prior to induction of anaesthesia. Anaesthesia 2004, 59:1020-1022.
55. Yuan Y.D., Seak C.J., Lin C.C., et al. Thyroid storm precipitated by organophosphate intoxication. Am J Emerg Med 2007, 25:861.
56. Samaras K., Marel G.M. Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of protracted amiodarone-induced thyroiditis. Clin Endocrinol 1996, 45:365-368.
57. Noh K.W., Seon C.S., Choi J.W., et al. Thyroid storm and reversible thyrotoxic cardiomyopathy after ingestion of seafood stew thought to contain marine neurotoxin. Thyroid 2011, 21:679-682.
58. Riis A.L., Gravholt C.H., Djurhuus C.B., et al. Elevated regional lipolysis in hyperthyroidism. J Clin Endocrinol Metab 2002, 87:4747-4753.
59. Aiello D.P., DuPlessis A.J., Pattishall E.G., et al. Thyroid storm presenting with coma and seizures. Clin Pediatr (Phila) 1989, 28:571-574.
60. Lee T.G., Ha C.K., Lim B.H. Thyroid storm presenting as status epilepticus and stroke. Postgrad Med J 1997, 73:61.
61. Dai A., Wasay M., Dubey N., et al. Superior sagittal sinus thrombosis secondary to hyperthyroidism. J Stroke Cerebrovasc Dis 2000, 9:89-90.
62. Lu K.C., Hsu Y.J., Chiu J.S., et al. Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis. Am J Emerg Med 2004, 22:544-547.
63. Feroza M., May H. Apathetic thyrotoxicosis. Int J Clin Pract 1997, 51:332-333.
64. Jao Y.T., Chen Y., Lee W.H., et al. Thyroid storm and ventricular tachycardia. South Med J 2004, 976:604-607.
65. Daly M.J., Wilson C.M., Dolan S.J., et al. Reversible dilated cardiomyopathy associated with post-partum thyrotoxic storm. QJM 2009, 102:217-219.
66. Opdahl H., Eritsland J., Sovik E. Acute myocardial infarction and thyrotoxic storm-a difficult and dangerous combination. Acta Anaesthesiol Scand 2005, 49:707-711.
67. Lee S.M., Jung T.S., Hahm J.R., et al. Thyrotoxicosis with coronary spasm that required coronary artery bypass surgery. Intern Med 2007, 46:1915-1918.
68. Liu Y.C., Tsai W.S., Chau T., et al. Acute hypercapnic respiratory failure due to thyrotoxic periodic paralysis. Am J Med Sci 2004, 327:264-267.
69. Mezosi E., Szabo J., Nagy E.V., et al. Nongenomic effect of thyroid hormone on free-radical production in human polymorphonuclear leukocytes. J Endocrinol 2005, 185:121-129.
70. Luong K.V., Nguyen L.T. Hyperthyroidism and asthma. J Asthma 2000, 37:125-130.
71. Barczynski M., Thor P. Reversible autonomic dysfunction in hyperthyroid patients affects gastric myoelectrical activity and emptying. Clin Auton Res 2001, 114:243-249.
72. Bhattacharyya A., Wiles P.G. Thyrotoxic crisis presenting as acute abdomen. J R Soc Med 1997, 90:681-682.
73. Cansler C.L., Latham J.A., Brown P.M., et al. Duodenal obstruction in thyroid storm. South Med J 1997, 90:1143-1146.
74. Leow M.K., Chew D.E., Zhu M., et al. Thyrotoxicosis and acute abdomen: still as defying and misunderstood today? Brief observations over the recent decade. QJM 2008, 101:943-947.
75. van Hoek I., Daminet S. Interactions between thyroid and kidney function in pathological conditions of these organ systems: a review. Gen Comp Endocrinol 2008, 160:205-215.
76. Goswami R., Seth A., Goswami A.K., et al. Prevalence of enuresis and other bladder symptoms in patients with active Graves' disease. Br J Urol 1997, 804:563-566.
77. Kahara T., Yoshizawa M., Nakaya I., et al. Thyroid crisis following interstitial nephritis. Intern Med 2008, 47:1237-1240.
78. Homonick M., Gessl A., Ferlitsch A., et al. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 2007, 92:3006-3012.
79. Romualdi E., Squizzato A., Ageno W. Venous thrombosis: a possible complication of overt hyperthyroidism. Eur J Intern Med 2008, 19:386-387.
80. Pekdemir M., Yilmaz S., Ersel M., et al. A rare cause of headache; cerebral venous sinus thrombosis due to hyperthyroidism. Am J Emerg Med 2008, 26:383.
81. Osman F., Gamma M.D., Sheppard M.C., et al. Clinical review 142: cardiac dysrhythmias and thyroid dysfunction: the hidden menace?. J Clin Endocrinol Metab 2002, 87:963-967.
82. Squizzato A., Gerdes V.E. Thyroid disease and haemostasis: a relationship with clinical implications?. Thromb Haemost 2008, 100:727-728.
83. Lippi G., Franchini M., Targher G., et al. Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients. J Thromb Thrombolysis 2008, 28:362-365.
84. Wartofsky L. The low T3 or 'sick euthyroid syndrome': update 1994. Endocrine Reviews monographs. 3. Clinical and molecular aspects of diseases of the thyroid 1994, 248-251. The Endocrine Society, Bethesda (MD). L.E. Braverman, S. Refetoff (Eds.).
85. Burch H.B., Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 1993, 22:263-277.
86. Kobayashi C., Sasaki H., Kosuge K., et al. Severe starvation hypoglycemia and congestive heart failure induced by thyroid crisis, with accidentally induced severe liver dysfunction and disseminated intravascular coagulation. Intern Med 2005, 44:234-239.
87. Bahn Chair R.S., Burch H.B., Cooper D.S., et al. American Thyroid Association; American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011, 21:593-646.
88. Nareem N., Miner D.J., Amatruda J.M. Methimazole: an alternative route of administration. J Clin Endocrinol Metab 1982, 54:180-181.
89. Yeung S.C., Go R., Balasubramanyam A. Rectal administration of iodide and propylthiouracil in the treatment of thyroid storm. Thyroid 1995, 5:403-405.
90. Zweig S.B., Schlosser J.R., Thomas S.A., et al. Rectal administration of propylthiouracil in suppository form in patients with thyrotoxicosis and critical illness: case report and review of literature. Endocr Pract 2006, 12:43-47.
91. Ogiso S., Inamoto S., Hata H., et al. Successful treatment of gastric perforation with thyrotoxic crisis. Am J Emerg Med 2008, 26:3-4.
92. Thomas D.J., Hardy J., Sarwar R., et al. Thyroid storm treated with intravenous methimazole in patients with gastrointestinal dysfunction. Br J Hosp Med (Lond) 2006, 67:492-493.
93. Weissel M. Withdrawal of the parenterally applicable form of thyrostatic drugs in Austria. Thyroid 2005, 15:1203.
94. Sowiński J., Junik R., Gembicki M. Effectiveness of intravenous administration of methimazole in patients with thyroid crisis. Endokrynol Pol 1988, 39:67-73.
95. Wartofsky L., Ransil B.J., Ingbar S.H. Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J Clin Invest 1970, 49:78-86.
96. Boehm T.M., Burman K.D., Barnes S., et al. Lithium and iodine combination therapy for thyrotoxicosis. Acta Endocrinol (Copenh) 1980, 94:174-183.
97. Reed J., Bradley E.L. Postoperative thyroid storm after lithium preparation. Surgery 1985, 98:983-986.
98. Vyas A.A., Vyas P., Fillipon N.L., et al. Successful treatment of thyroid storm with plasmapheresis in a patient with methimazole-induced agranulocytosis. Endocr Pract 2010, 16:673-676.
99. Ozbey N., Kalayoglu-Besisik S., Gul N., et al. Therapeutic plasmapheresis in patients with severe hyperthyroidism in whom antithyroid drugs are contraindicated. Int J Clin Pract 2004, 58:554-558.
100. Ezer A., Caliskan K., Parlakgumus A., et al. Preoperative therapeutic plasma exchange in patients with thyrotoxicosis. J Clin Apher 2009, 24:111-114.
101. Enghofer M., Badenhoop K., Zeuzem S., et al. Fulminant hepatitis A in a patient with severe hyperthyroidism; rapid recovery from hepatic coma after plasmapheresis and total thyroidectomy. J Clin Endocrinol Metab 2000, 85:1765-1769.
102. Burman K.D., Yeager H.C., Briggs W.A., et al. Resin hemoperfusion: a method of removing circulating thyroid hormones. J Clin Endocrinol Metab 1976, 42:70-78.
103. Candrina R., DiStefano O., Spandrio S., et al. Treatment of thyrotoxic storm by charcoal plasmaperfusion. J Endocrinol Invest 1989, 12:133-134.
104. Solomon B.L., Wartofsky L., Burman K.D. Adjunctive cholestyramine therapy for thyrotoxicosis. Clin Endocrinol (Oxf) 1993, 38:39-43.
105. Hughes G. Management of thyrotoxic crisis with a beta-adrenergic blocking agent (pronethalol). Br J Clin Pract 1966, 20:579-581.
106. Feely J., Forrest A., Gunn A., et al. Propranolol dosage in thyrotoxicosis. J Clin Endocrinol Metab 1980, 51:658-661.
107. Rubenfeld S., Silverman V.E., Welch K.M., et al. Variable plasma propranolol levels in thyrotoxicosis. N Engl J Med 1979, 300:353-354.
108. Wiersinga W.M. Propranolol and thyroid hormone metabolism. Thyroid 1991, 1:273-277.
109. Brunette D.D., Rothong C. Emergency department management of thyrotoxic crisis with esmolol. Am J Emerg Med 1991, 9:232-234.
110. Knighton J.D., Crosse M.M. Anaesthetic management of childhood thyrotoxicosis and the use of esmolol. Anaesthesia 1997, 52:67-70.
111. 131I induced thyroid storm after discontinuing glucocorticoid therapy. Wis Med J 1991, 90:463-465.
112. Kawakami-Tani T., Fukawa E., Tanaka H., et al. Effect of alpha hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease. Metabolism 1997, 46:1184-1188.
113. Benvenga S., Lapa D., Cannavo S., et al. Successive thyroid storms treated with l-carnitine and low doses of methimazole. Am J Med 2003, 115:417-418.
114. Benvenga S., Ruggeri R.M., Russo A., et al. Usefulness of l-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 2001, 86:3579-3594.
115. Bennett M.H., Wainwright A. Acute thyroid crisis on induction of anesthesia. Anaesthesia 1989, 44:28-30.
116. Dillman W.H. Thyroid storm. Curr Ther Endocrinol Metab 1997, 6:81-85.
117. Tietgens S.T., Leinung M.C. Thyroid storm. Med Clin North Am 1995, 79:169-184.
118. Leow M.K., Loh K.C. Fatal thyroid crisis years after two thyroidectomies for Graves' disease: is thyroid tissue auto transplantation for postthyroidectomy hypothyroidism worthwhile?. J Am Coll Surg 2002, 195:434-435.